Rollover Protocol for Prior SU011248 Protocols

Pfizer

Status: Completed

Conditions: Solid Tumors

Treatments: Drug: Sunitinib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00798889

A6181030

Details and patient eligibility

About

The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol

Enrollment: 314 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Prior SU011248 Protocol.
• Eligible to continue SU011248 treatment.

Exclusion criteria

• Uncontrolled CNS metastasis.
• Unfit to receive SU011248.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

314 participants in 1 patient group

Sunitinib

Experimental group

Treatment:

Drug: Sunitinib